LifeClean International AB

LifeClean International AB

SSTO:LCLEAN
0.02
SEK
+0.00
(+20.63%)
-0.06EPS
37.00MMarket Cap
Feb 18Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.04
0.03
0.48
- -
0.66
0.68
0.67
0.2
0.12
Basic EPS, GAAP
-0.13
-0.15
-0.05
- -
-0.51
-0.57
-0.59
-0.13
-0.06
Free Cash Flow per Basic Share
-0.08
-0.16
-0.19
- -
-0.28
-0.52
-0.47
-0.1
-0.05
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.19
0.22
0.96
0.7
0.19
0.02
-0.04
0.01
0.03
Tangible Book Value per Share
-0.05
-0.02
0.73
0.27
-0.18
-0.29
-0.24
-0.03
0.02
Basic Weighted Avg Shares
68
68
66
69
71
78
92
274
511
Sales/Revenue/Turnover
3
2
32
- -
47
53
61
55
59
Operating Margin (%)
-334.56
-426.13
-9.2
- -
-74.35
-78.75
-82.07
-63.26
-47.66
Depreciation Expense
2
3
3
- -
9
9
9
9
6
Net Income, GAAP
-9
-10
-3
- -
-36
-44
-54
-36
-29
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-347.6
-438.9
-10.08
- -
-76.49
-84.26
-87.85
-65.27
-48.63
Working Capital
- -
1
46
13
-7
-18
1
-7
27
LT Debt
5
3
3
10
20
17
34
11
9
Total Equity
13
15
65
50
14
1
-4
3
38
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-74.7
-8.04
- -
-113.29
-584.77
- -
- -
- -

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
17
12
4
LT Borrowings
11
10
9
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
274
338
1,156
Market Capitalization
26
18
37

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
25
22
46
Cash, Cash Equivalents & STI
7
2
26
Accounts Receivable, Net
6
7
6
Inventories
11
11
12
Total Current Liabilities
32
29
19
Payables & Accruals
- -
- -
- -
ST Debt
17
12
4
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-150.95%
-192.65%
Free Cash Flow
- -
- -
-33.6%
Net Income, GAAP
- -
- -
-33.62%
Sales/Revenue/Turnover
- -
- -
-10.66%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
16
21
14
10
61
2025
15
20
- -
10
55
2026
15
13
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.18
-0.16
-0.14
-0.14
-0.59
2025
-0.1
-0.03
- -
-0.03
-0.13
2026
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Anders Lundström
Full Time Employees
22
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Kärrastrandvägen 124B Uddevalla VG Sweden 451 76
IPO Date
Oct 1, 2020
Business
LifeClean International AB is a Sweden-based cleantech company specializing in research, production, marketing, and sales of disinfection and cleaning solutions. The company offers a patented disinfectant technology effective against a broad spectrum of microorganisms including bacteria, viruses, fungi, spores, biofilms, and PFAS (per- and polyfluoroalkyl substances) contaminants. Its core product lines include high-level disinfection solutions for healthcare and agriculture sectors, as well as innovative chemical solutions for environmental decontamination, particularly PFAS removal. LifeClean’s disinfectants are known for rapid efficacy, broad-spectrum antimicrobial action, and minimal environmental residues, serving industries focused on infection prevention, food safety, and environmental protection. The company operates internationally with a primary focus on Sweden and expanding global markets, leveraging strategic partnerships such as a notable alliance with Arxada for exclusive European distribution. Founded in 2012 and headquartered in Uddevalla, Sweden, LifeClean is accelerating growth through recent acquisitions including Kempartner AB and Kemibolaget Ocean AB, which expand its production capacity, private-label chemical manufacturing capabilities, and product portfolio under the Ocean brand. These acquisitions enable LifeClean to integrate climate-neutral chemical production and broaden its market reach across professional and consumer cleaning segments. LifeClean’s business segments encompass healthcare disinfection, agriculture hygiene, and environmental cleantech with scalable production facilities equipped for both liquid and powder chemical products. The company also maintains subsidiaries Kempartner AB and Kemibolaget Ocean AB, ensuring synergy in product development, research, and private-label contract manufacturing. Recent developments include a SEK 32 million directed share issue to fund growth initiatives, an emphasis on innovation in green chemistry, and product launches that reinforce regulatory compliance and environmental sustainability, positioning LifeClean as a leading cleantech and infection prevention company with a comprehensive portfolio of disinfectants and cleaning solutions. LifeClean's patented disinfectant is scientifically validated to meet international standards such as EN-norms and offers a practical solution across microbial challenges relevant in healthcare, agriculture, and industrial hygiene. The company emphasizes environmental responsibility through biodegradable formulations that avoid harmful residue accumulation while providing sterilization efficacy for a broad range of applications including poultry production, healthcare facilities, and environmental remediation. In summary, LifeClean International AB is a public, innovative chemical technology company that develops, manufactures, and markets premium disinfectant and cleaning products with a strong focus on antimicrobial resistance mitigation, environmental cleantech solutions, and scalable production capabilities, highlighted by recent strategic acquisitions and partnerships to drive international growth and product diversification.